A hematologist outlines how the new drugs can help treat coagulation triggered by rheumatological diseases
Two Inflammatory Conditions—Polymyalgia Rheumatica and Giant Cell Arteritis—Share Clinical Connection
Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) have common clinical and epidemiologic links, but they need not occur synchronously
A Spotlight on IgG4-Related Disease
What rheumatologists need to know about identifying and diagnosing immunoglobulin G4-related disease (IgG4-RD)
Letter: No European Consensus on Steroid Use in Rheumatoid Arthritis
There is not a consensus between all European rheumatologists regarding the use of steroids in RA; quite a few share your skepticism, including myself.
Clinical Opportunities at the 2012 ACR/ARHP Annual Meeting
The Annual Meeting will provide numerous opportunities to learn the latest clinical findings in the field and to update their knowledge in all aspects of rheumatology.
Translational Rheumatology
Changes to the NIH CTSA program may bring more support to bench-to-bedside research
New GIOP Guidelines Available
The ACR published new recommendations for the management of glucocorticoid-induced osteoporosis (GIOP) in the November issue of Arthritis Care & Research. These guidelines have been endorsed by the American Society for Bone and Mineral Research. They apply to adult patients receiving oral glucocorticoid therapy.
Is Acupuncture for Pain a Placebo Treatment?
An examination of the evidence
Clinical Opportunities at the Annual Meeting: A Fellow’s Perspective
Over the years, the ACR/ARHP Annual Scientific Meeting has provided exceptional opportunities for all attendees, but it can be especially beneficial for rheumatology fellows, and this year’s annual meeting in Atlanta is no exception. The ACR Annual Meeting Planning Committee and the Fellows Subcommittee will facilitate several educational, mentoring, social, and networking programs specifically for the benefit of fellows.
Practical Medication Management
Take a firm stand in perioperative and pregnant patients with rheumatic disease